Key MicroRNA’s and Their Targetome in Adrenocortical Cancer

Chehade, Marthe; Bullock, Martyn; Glover, Anthony; Hutvagner, Gyorgy; Sidhu, Stan

doi:10.3390/cancers12082198

Open AccessReview

Key MicroRNA’s and Their Targetome in Adrenocortical Cancer

by

Marthe Chehade

^1,2,

Martyn Bullock

^1,2

,

Anthony Glover

^1,2,3

,

Gyorgy Hutvagner

^4,*

and

Stan Sidhu

^1,2,3,*

¹

Cancer Genetics Laboratory, Kolling Institute, Northern Sydney Local Health District, St. Leonards, NSW 2065, Australia

²

Sydney Medical School Northern, Royal North Shore Hospital, University of Sydney, Sydney, NSW 2065, Australia

³

Endocrine Surgery Unit, Royal North Shore Hospital, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, St. Leonards, Sydney, NSW 2007, Australia

⁴

School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, NSW 2007, Australia

^*

Authors to whom correspondence should be addressed.

Cancers 2020, 12(8), 2198; https://doi.org/10.3390/cancers12082198

Submission received: 14 June 2020 / Revised: 27 July 2020 / Accepted: 28 July 2020 / Published: 6 August 2020

(This article belongs to the Special Issue Role of miRNAs in Cancer—Analysis of Their Targetome)

Download

Browse Figures

Versions Notes

Abstract

Adrenocortical Carcinoma (ACC) is a rare but aggressive malignancy with poor prognosis and limited response to available systemic therapies. Although complete surgical resection gives the best chance for long-term survival, ACC has a two-year recurrence rate of 50%, which poses a therapeutic challenge. High throughput analyses focused on characterizing the molecular signature of ACC have revealed specific micro-RNAs (miRNAs) that are associated with aggressive tumor phenotypes. MiRNAs are small non-coding RNA molecules that regulate gene expression by inhibiting mRNA translation or degrading mRNA transcripts and have been generally implicated in carcinogenesis. This review summarizes the current insights into dysregulated miRNAs in ACC tumorigenesis, their known functions, and specific targetomes. In addition, we explore the possibility of particular miRNAs to be exploited as clinical biomarkers in ACC and as potential therapeutics.

Keywords: adrenocortical carcinoma; micro RNA; non-coding RNA

Share and Cite

MDPI and ACS Style

Chehade, M.; Bullock, M.; Glover, A.; Hutvagner, G.; Sidhu, S. Key MicroRNA’s and Their Targetome in Adrenocortical Cancer. Cancers 2020, 12, 2198. https://doi.org/10.3390/cancers12082198

AMA Style

Chehade M, Bullock M, Glover A, Hutvagner G, Sidhu S. Key MicroRNA’s and Their Targetome in Adrenocortical Cancer. Cancers. 2020; 12(8):2198. https://doi.org/10.3390/cancers12082198

Chicago/Turabian Style

Chehade, Marthe, Martyn Bullock, Anthony Glover, Gyorgy Hutvagner, and Stan Sidhu. 2020. "Key MicroRNA’s and Their Targetome in Adrenocortical Cancer" Cancers 12, no. 8: 2198. https://doi.org/10.3390/cancers12082198

APA Style

Chehade, M., Bullock, M., Glover, A., Hutvagner, G., & Sidhu, S. (2020). Key MicroRNA’s and Their Targetome in Adrenocortical Cancer. Cancers, 12(8), 2198. https://doi.org/10.3390/cancers12082198

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Key MicroRNA’s and Their Targetome in Adrenocortical Cancer

Abstract

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI